| First Author | Ulivieri C | Year | 2011 |
| Journal | J Immunol | Volume | 186 |
| Issue | 9 | Pages | 5095-106 |
| PubMed ID | 21430228 | Mgi Jnum | J:172861 |
| Mgi Id | MGI:5009152 | Doi | 10.4049/jimmunol.1001391 |
| Citation | Ulivieri C, et al. (2011) p66Shc is a negative regulator of FcepsilonRI-dependent signaling in mast cells. J Immunol 186(9):5095-106 |
| abstractText | Aggregation of FcepsilonRI on mast cells activates signaling pathways, resulting in degranulation and cytokine release. Release of mast cell-derived inflammatory mediators is tightly regulated by the interplay of positive and negative signals largely orchestrated by adapter proteins. Among these, the Shc family adapter p52Shc, which couples immunoreceptors to Ras activation, positively regulates FcepsilonRI-dependent signaling. Conversely, p66Shc was shown to uncouple the TCR for the Ras-MAPK pathway and prime T cells to undergo apoptotic death. Loss of p66Shc in mice results in breaking of immunologic tolerance and development of lupus-like autoimmune disease, which includes alopecia among its pathological manifestations. The presence of numerous activated mast cells in alopecic skin areas suggests a role for this adapter in mast cells. In this study, we addressed the involvement of p66Shc in FcepsilonRI-dependent mast cell activation. We showed that p66Shc is expressed in mast cells and that mast cells from p66Shc(-/-) mice exhibit enhanced responses following Ag stimulation of FcepsilonRI. Furthermore, using RBL-2H3 cell transfectants, we showed that aggregation of FcepsilonRI resulted in the recruitment of a p66Shc-SHIP1 complex to linker for activation of T cells. Collectively, our data identified p66Shc as a negative regulator of mast cell activation. |
